220
Participants
Start Date
November 25, 2019
Primary Completion Date
December 31, 2028
Study Completion Date
June 30, 2031
Alpha 1-Antitrypsin
Kamada's alpha 1-antitrypsin product given by inhalation using the eFlow® electronic nebulizer manufactured by PARI Pharma GmbH
Placebo
Preparation of NaCl in phosphate buffer solution with 0.01% TWEEN-80
RECRUITING
University Hospital (UZ) Leuven, Leuven
RECRUITING
Tays Central Hospital, Tampere
RECRUITING
Beaumont Hospital, Dublin
RECRUITING
Leiden University Medical Center (LUMC), Leiden
RECRUITING
Canisius Wilhelmina Hospital (CWZ), Nijmegen
RECRUITING
Skåne University Hospital, Malmo
RECRUITING
University Hospitals Birmingham NHS Foundation Trust, Birmingham
RECRUITING
Royal Infirmary of Edinburgh, Edinburgh
RECRUITING
University Hospital Southampton NHS Foundation Trust, Southampton
Collaborators (1)
Syneos Health
OTHER
Kamada, Ltd.
INDUSTRY